Press release
RNAi Therapeutics Market Trends, Growth & Forecast 2024-2031 | Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation.
The RNAi Therapeutics Market study by DataM Intelligence provides a comprehensive analysis of the market, delivering valuable insights, detailed statistics, historical trends, and industry-backed market data. The report explores the competitive landscape, focusing on key players in the industry. It evaluates aspects such as product offerings, pricing models, financial performance, product portfolios, growth strategies, and regional expansion to offer a thorough understanding of market dynamics and future trends.Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/rnai-therapeutics-market?sz
What is the projected growth of the Global RNAi Therapeutics market?
The Global RNAi Therapeutics Market is estimated to reach at a CAGR 17.4% during the forecast period (2024-2031).
What is RNAi Therapeutics Market?
The RNAi Therapeutics Market focuses on RNA interference-based drugs that silence disease-causing genes, offering targeted treatments for genetic disorders, cancer, and viral infections. Driven by advancements in biotechnology, increasing FDA approvals, and rising demand for precision medicine, the market is expanding. Growth in nanoparticle drug delivery and investment in RNA-based therapies further accelerate adoption.
Transform your pharma strategy with expert insights and competitive analysis: https://www.datamintelligence.com/competitive-intelligence/contact
Who are the major players in the RNAi Therapeutics market?
The prominent players in RNAi Therapeutics market research report are:
Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation, Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics, Inc.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
On February 26, 2020, Alnylam Pharmaceuticals, a leader in RNAi therapeutics, announced that the Brazilian Health Regulatory Agency (ANVISA) had approved ONPATTRO for treating hereditary transthyretin-mediated (hATTR) amyloidosis in adults. This approval marks a significant step in expanding treatment options for patients with this rare and progressive disease.
In June 2020, OliX Pharmaceuticals partnered with LGC Biosearch Technologies to accelerate the production of asymmetric siRNA for treating subretinal fibrosis and wet macular degeneration. This collaboration aims to enhance the development of innovative RNA-based therapies for vision-related disorders.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/rnai-therapeutics-market
Market Segments
By Type: Small Interfering RNAs (siRNA), MicroRNA (miRNA).
By Application: Oncology, Cardiovascular, Respiratory Disorders, Renal Diseases, Genetic Disorders, Neurodegenerative Disorders, Infectious Diseases, Others.
By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Others.
By End-User: Hospitals, Research and Academic Laboratories, Diagnostic Laboratories.
The RNAi Therapeutics industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global RNAi Therapeutics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/rnai-therapeutics-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Therapeutics Market Trends, Growth & Forecast 2024-2031 | Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation. here
News-ID: 3888236 • Views: …
More Releases from DataM Intelligence 4Market Research

United States Blockchain Market Set to Revolutionize Industries with Unprecedent …
Market Overview:
The Global Block Chain Market is expected to reach at a CAGR of 56.1% during the forecast period 2024-2031.
The Blockchain Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Blockchain market report is an essential resource for market participants…

United States Evaporative Cooling Market Surges as Demand for Sustainable, Energ …
Market Size and Growth:
The Global Evaporative Cooling Market size reached US$ 6.51 billion in 2023 and is expected to reach US$ 10.24 billion by 2031, growing with a CAGR of 5.83% during the forecast period 2024-2031.
The Evaporative Cooling Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…

United States Hybrid Power Solution Market Surges Ahead: Driving Energy Efficien …
Market Overview:
The Hybrid Power Solution Market is expected to reach at a Significant CAGR during the forecast period (2024-2031).
The Hybrid Power Solution Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Hybrid Power Solution market report is an essential resource…

United States Next Generation Advanced Batteries Market Set to Revolutionize Glo …
Market Size and Growth:
The Global Next Generation Advanced Batteries Market size reached US$1.95 billion in 2024 and is expected to reach US$3.41 billion by 2032, growing with a CAGR of 7.24% during the forecast period 2025-2032
The Next Generation Advanced Batteries Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…